Mounjaro and Zepbound are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
In the sermorelin vs CJC-1295 vs ipamorelin comparison, sermorelin and CJC-1295 are both GHRH analogues that activate the GHRH receptor on pituitary cells they differ primarily in half-life (sermorelin: 10-20 minutes, CJC-1295 no DAC: ~30 minutes, CJC-1295 with DAC: 6-8 days)
doi:10.2165/00126839-200405040-00011 Graul, A I, Prous, JR (2006)
Nov 16 2022;23(22)doi:10.3390/ijms232214183
Mounjaro (tirzepatide) A newer medication that combines two hormones, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), Tirzepatide (Mounjaro/Zepbound): Dual GIP/GLP-1 agonist
Harris can adjust dosage timing, increase steps more gradually, or provide supportive guidance whenever needed